Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study

BACKGROUND: Reduced ethambutol serum concentrations are commonly observed among TB patients co-infected with HIV and may lead to treatment failure. OBJECTIVES: To perform a population pharmacokinetic study of ethambutol in HIV/TB patients, and to evaluate an intensified ethambutol weight-based dosin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Antimicrob Chemother
Main Authors: Mehta, Krina, Ravimohan, Shruthi, Pasipanodya, Jotam G, Srivastava, Shashikant, Modongo, Chawangwa, Zetola, Nicola M, Weissman, Drew, Ivaturi, Vijay, Gumbo, Tawanda, Bisson, Gregory P, Vinnard, Christopher
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6753485/
https://ncbi.nlm.nih.gov/pubmed/31273386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz265
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados